What is Ironwood Pharmaceuticals, Inc. - Class A's Market Cap?

Ironwood Pharmaceuticals, Inc. - Class A's Market Cap is $689.1M, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's Trailing P/E?

Ironwood Pharmaceuticals, Inc. - Class A's Trailing P/E is 5.3×, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's Price / Sales?

Ironwood Pharmaceuticals, Inc. - Class A's Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's Revenue (TTM)?

Ironwood Pharmaceuticals, Inc. - Class A's Revenue (TTM) is $389.3M, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's Net Income (TTM)?

Ironwood Pharmaceuticals, Inc. - Class A's Net Income (TTM) is $129.9M, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's EBITDA?

Ironwood Pharmaceuticals, Inc. - Class A's EBITDA is $235.3M, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's Diluted EPS (TTM)?

Ironwood Pharmaceuticals, Inc. - Class A's Diluted EPS (TTM) is 0.79, based on as-reported figures from SEC (XBRL) filings.

What is Ironwood Pharmaceuticals, Inc. - Class A's EBITDA Margin?

Ironwood Pharmaceuticals, Inc. - Class A's EBITDA Margin is 60.4%, based on as-reported figures from SEC (XBRL) filings.

Ironwood Pharmaceuticals, Inc. - Class A (IRWD) Financial Statements

Ironwood Pharmaceuticals, Inc. - Class A

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SNZLM7

XNAS · usd

4.17▼ 0.09 (-2.11%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close4.26

Day's Range4.08 – 4.27

52-Week Range1.05 – 5.78

Volume2.3M

Avg Volume2.0M

Share Statistics

Shares Outstanding

Employees100

ExchangeXNAS

Listed2010-02-03

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Ironwood Pharmaceuticals, Inc. - Class A (IRWD)

What is Ironwood Pharmaceuticals, Inc. - Class A's Market Cap?: Ironwood Pharmaceuticals, Inc. - Class A's Market Cap is $689.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's Trailing P/E?: Ironwood Pharmaceuticals, Inc. - Class A's Trailing P/E is 5.3×, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's Price / Sales?: Ironwood Pharmaceuticals, Inc. - Class A's Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's Revenue (TTM)?: Ironwood Pharmaceuticals, Inc. - Class A's Revenue (TTM) is $389.3M, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's Net Income (TTM)?: Ironwood Pharmaceuticals, Inc. - Class A's Net Income (TTM) is $129.9M, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's EBITDA?: Ironwood Pharmaceuticals, Inc. - Class A's EBITDA is $235.3M, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's Diluted EPS (TTM)?: Ironwood Pharmaceuticals, Inc. - Class A's Diluted EPS (TTM) is 0.79, based on as-reported figures from SEC (XBRL) filings.
What is Ironwood Pharmaceuticals, Inc. - Class A's EBITDA Margin?: Ironwood Pharmaceuticals, Inc. - Class A's EBITDA Margin is 60.4%, based on as-reported figures from SEC (XBRL) filings.